Participants 32 56 5
healthy adults in China.
Participants 131 147 3
adults in China.
Participants 274 429 7
randomized 5143 healthy adults received 10 Î¼g hepatitis B vaccine at 0, 1 and 3 months(group A), 0, 1 and 6 months(group B), or 0, 1 and 12 months(group C
Participants 680 752 4
udy, 2438 healthy adults finished the full vaccination program and follo
